Search research articles
Contact Us
Filters
Showing results (11-20 of 69) with videos related to
Page
of 7
Sort By:
Rapid Communications in Mass Spectrometry : RCM
|
September 3, 2015
Glutathione trapping of reactive drug metabolites produced by biomimetic metalloporphyrin catalysts
Toni Lassila, Sampo Mattila, Miia Turpeinen, et al.
Journal of Chromatography. A
|
November 21, 2008
Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2 microm particle size column
Aleksanteri Petsalo, Miia Turpeinen, Olavi Pelkonen, et al.
Archives of Toxicology
|
October 7, 2020
CYP-associated drug-drug interactions: A mission accomplished?
Olavi Pelkonen, Jukka Hakkola, Janne Hukkanen, et al.
Rapid Communications in Mass Spectrometry : RCM
|
July 11, 2015
Glutathione trapping of reactive drug metabolites produced by biomimetic metalloporphyrin catalysts
Toni Lassila, Sampo Mattila, Miia Turpeinen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 28, 2005
A simple method for differentiation of monoisotopic drug metabolites with hydrogen-deuterium exchange liquid chromatography/electrospray mass spectrometry
Ari Tolonen, Miia Turpeinen, Jouko Uusitalo, et al.
Biochemical and Biophysical Research Communications
|
June 11, 2002
Comparison of anti-p53 antibodies in immunoblotting
Miia Turpeinen, Raisa Serpi, Mika Rahkolin, et al.
Archives of Toxicology
|
October 28, 2020
Inhibition and induction of CYP enzymes in humans: an update
Jukka Hakkola, Janne Hukkanen, Miia Turpeinen, et al.
International Journal of Technology Assessment in Health Care
|
August 19, 2022
Implementation of a new Digi-HTA process for digital health technologies in Finland
Jari Haverinen, Miia Turpeinen, Petra Falkenbach, et al.
Analytical and Bioanalytical Chemistry
|
August 13, 2008
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
Ulrich M Zanger, Miia Turpeinen, Kathrin Klein, et al.
Basic & Clinical Pharmacology & Toxicology
|
March 1, 2005
Prediction of drug metabolism and interactions on the basis of in vitro investigations
Olavi Pelkonen, Miia Turpeinen, Jouko Uusitalo, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 69) with videos related to
Sort By:
Page
of 7
Rapid Communications in Mass Spectrometry : RCM
|
September 3, 2015
Glutathione trapping of reactive drug metabolites produced by biomimetic metalloporphyrin catalysts
Toni Lassila, Sampo Mattila, Miia Turpeinen, et al.
Journal of Chromatography. A
|
November 21, 2008
Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2 microm particle size column
Aleksanteri Petsalo, Miia Turpeinen, Olavi Pelkonen, et al.
Archives of Toxicology
|
October 7, 2020
CYP-associated drug-drug interactions: A mission accomplished?
Olavi Pelkonen, Jukka Hakkola, Janne Hukkanen, et al.
Rapid Communications in Mass Spectrometry : RCM
|
July 11, 2015
Glutathione trapping of reactive drug metabolites produced by biomimetic metalloporphyrin catalysts
Toni Lassila, Sampo Mattila, Miia Turpeinen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 28, 2005
A simple method for differentiation of monoisotopic drug metabolites with hydrogen-deuterium exchange liquid chromatography/electrospray mass spectrometry
Ari Tolonen, Miia Turpeinen, Jouko Uusitalo, et al.
Biochemical and Biophysical Research Communications
|
June 11, 2002
Comparison of anti-p53 antibodies in immunoblotting
Miia Turpeinen, Raisa Serpi, Mika Rahkolin, et al.
Archives of Toxicology
|
October 28, 2020
Inhibition and induction of CYP enzymes in humans: an update
Jukka Hakkola, Janne Hukkanen, Miia Turpeinen, et al.
International Journal of Technology Assessment in Health Care
|
August 19, 2022
Implementation of a new Digi-HTA process for digital health technologies in Finland
Jari Haverinen, Miia Turpeinen, Petra Falkenbach, et al.
Analytical and Bioanalytical Chemistry
|
August 13, 2008
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
Ulrich M Zanger, Miia Turpeinen, Kathrin Klein, et al.
Basic & Clinical Pharmacology & Toxicology
|
March 1, 2005
Prediction of drug metabolism and interactions on the basis of in vitro investigations
Olavi Pelkonen, Miia Turpeinen, Jouko Uusitalo, et al.
Page
of 7